1 / 22

Idiopathic Perifoveal Telangiectasia

Idiopathic Perifoveal Telangiectasia. Laura S Gilmore, MD Department of Ophthalmology TTUHSC March 12, 2004 Discussant: Kelly T Mitchell, MD. Case Presentation. CC: decreased VA

Antony
Télécharger la présentation

Idiopathic Perifoveal Telangiectasia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Idiopathic Perifoveal Telangiectasia Laura S Gilmore, MD Department of Ophthalmology TTUHSC March 12, 2004 Discussant: Kelly T Mitchell, MD

  2. Case Presentation CC: decreased VA HPI: 56yo WF with sudden onset of decreased VA September, 2003, progressively worsening; denies past ocular disease or injury PMH/ROS: wheelchair-bound 3 months 2o disc disease, hearing loss since birth, fibromyalgia, peripheral neuropathy, poor circulation, arthritis, anemia, Raynaud’s Disease, ataxia, skin rashes, arythmia FH: glaucoma, diabetes Meds: Seroquel, Procardia, Diazide, Soma, B12, Levbid, Paxil, Lasix, Darvocet Allergies: “need to mail list”

  3. Physical Exam VA: 20/100 OU 2/5/04; 20/400 OU 2/24/04 IOP: 16 OU VS: 110/78, P 80 Pupils: 5 to 3 OU, 0 APD Motility: Full OU VF: mild, equal constriction OU AC: trace NSC OU; 4+DQ; quiet; corneas clear Fundus: Small hyperpigmented areas temporal to maculas OU

  4. OCT

  5. Visual Field

  6. Differential Diagnosis • Diabetic retinopathy • Venous occlusive disease • Coat’s disease • Idiopathic Perifoveal Telangiectasia • CME 2o uveitis • Lamellar macular hole • Eales’ disease • CSR

  7. Basics of IPT • Dilation and incompetence of retinal capillaries • Solely in perifoveal area • Bilateral • IPT = Group 2A of Gass Classification of perifoveal telangiectasia • Probably acquired • By definition, no associated retinal vascular diseases

  8. Distinguishing Features of IPT • Most important distinguishing feature is the limitation to perifoveal macular region • Small refractile golden crystalline deposits in 50% • Yellow foveal lesion in one or both eyes in 5% • No progression • Bilateral • Usually presents at 50-60 years • No sex predilection • No lipid (seen in CSR, choroidal neovascularization, DR, Coat’s disease

  9. Typical Presentation • Decreased VA to 20/30 or better • Area of telangiectasia <1DD, confined to temporal macula • Only minimal intraretinal serous exudation • No lipid exudation

  10. Gass Classification • Group 1A: unilateral, congenital parafoveolar telangiectasia • Group 1B: unilateral, idiopathic, focal PFT • Group 2A: bilateral, idiopathic, acquired PFT • Group 2B: juvenile occult familial PFT, but no right-angled venules, crystals, or pigmented plaques • Group 3A: occlusive idiopathic PFT • Group 3B: occlusive idiopathic JFT associated with CNS vasculopathy

  11. Staging • Stage 1: mild staining of outer retina of temporal macula on FA • Stage 2: some graying of involved area, mild telangiectasias • Stage 3: severely blunted, dilated, right-angle venules diving deep into outer retinal plexus • Stage 4: stellate RPE plaques along right-angle venules 2o to RPE hyperplastic response • Stage 5: choroidal neovascularization, peculiar retinochoroidal anastamoses unique to this disease

  12. Pathogenesis and Histopathology • Possible genetic component • See thickened capillary endothelial wall of affected vessels • Extracellular fluid • Nutritional deprivation of middle retinal cells causes degeneration of outer retinal cell layers and outer retinal atrophy • RPE hyperplasia and migration along right-angle venules

  13. Complications • Only occur in 5% of pts • Subretinal neovascularization • Subretinal hemorrhage • VA worse than 20/50 • Disciform scar formation

  14. Treatment and Course • Disease is usually self-limited and VA STABLE • Laser is only considered with persistent, advanced disease • Laser is often not effective, because visual loss is due to atrophy, not serous exudation • PDT • Grid laser

  15. In Our Patient • Why the severe vision loss? • + edema • No CNVM • No SRH • No serous RD • Any connection with positive ROS? • How to treat her specifically…

More Related